| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT06432036 Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma… |
date change Primary completion pushed: 2026-06-01 -> 2029-03-24 |
| 2026-06-06 | NCT06432036 Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma… |
date change Completion pushed: 2027-06 -> 2030-03 |
| 2026-05-23 | NCT07468903 Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer |
Recruitment opened |
| 2026-05-23 | NCT07468903 Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer |
date change Primary completion pushed: 2031-04-04 -> 2031-05-11 |
| 2026-05-23 | NCT07468903 Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer |
date change Completion pushed: 2032-04-04 -> 2032-05-11 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07634601 Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic… | Phase 2 | Not Yet Recruiting |
| 2026-06-02 | NCT07619313 AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients… | Phase 1 | Not Yet Recruiting |
| 2026-05-28 | NCT07612293 STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection | Not Yet Recruiting | |
| 2026-05-26 | NCT07605546 RAD ONC FREEDOM Oncology Pain | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07461948 | Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in… | Glioblastoma | Recruiting |
| NCT06448286 | PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve… | Glioblastoma | Not Yet Recruiting |
| NCT03582774 | Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy | Recurrent Prostate Carcinoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT05775471 | Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical… | Renal Pelvis and Ureter Urothelial Carcinoma | Recruiting |
| NCT04712851 | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | Cervical Intraepithelial Neoplasia | Recruiting |
| NCT06216249 | Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment… | Prostate Carcinoma | Recruiting |
| NCT06288113 | Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant… | Castration-Resistant Prostate Carcinoma | Recruiting |
| NCT07323641 | Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06788938 | Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine… | DLL3-expressing Tumors | Recruiting |
| NCT06980077 | Ivonescimab for the Treatment of Thymic Cancer | Thymus Carcinoma | Recruiting |
| NCT06436612 | Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body… | Abdominopelvic Sarcomas | Recruiting |
| NCT03902951 | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate… | Metastatic Prostate Adenocarcinoma | Active, Not Recruiting |
| NCT07229339 | Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage… | Lung Non-Squamous Non-Small Cell Carcinoma | Not Yet Recruiting |
| NCT07242365 | Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and… | Locally Advanced Head and Neck Carcinoma | Active, Not Recruiting |
| NCT04395079 | Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With… | Metastatic Malignant Female Reproductive System Neoplasm | Active, Not Recruiting |
| NCT07468916 | Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative… | Atypical Chronic Myeloid Leukemia | Not Yet Recruiting |
| NCT03601455 | Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants… | Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT05496959 | 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of… | Oligometastatic Prostate Carcinoma | Active, Not Recruiting |
| NCT07634601 | Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic… | Advanced Endometrial Carcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05256641 | Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT05688215 | Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of… | Borderline Resectable Pancreatic Adenocarcinoma | Recruiting |
| NCT06432036 | Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma… | Stage I Renal Cell Cancer | Recruiting |
| NCT03830918 | Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors… | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT04285671 | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of… | Metastatic Lung Non-Small Cell Carcinoma | Active, Not Recruiting |
| NCT05319873 | Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer | Anatomic Stage II Breast Cancer AJCC v8 | Active, Not Recruiting |